Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 7, 2009Cancer ResearchOpen Access

Modification of Ovarian Cancer Risk by BRCA1/2 -Interacting Genes in a Multicenter Cohort of BRCA1/2 Mutation Carriers

View Full Paper
Ask AI
Bookmark
Share

Authors

TRTimothy R. RebbeckNMNandita MitraSDSusan M. Domchek

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rebbeck et al. (2009) studied this question.

synapsesocial.com/papers/6aa59c3ec616a76b5feecb45https://doi.org/10.1158/0008-5472.can-09-0625
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Genetic and Histopathologic Evaluation ofBRCA1andBRCA2DNA Sequence Variants of Unknown Clinical Significance2006 · 149 citations
  2. 2Breast and Ovarian Cancer in Relatives of Cancer Patients, with and without BRCA Mutations2006 · 40 citations
  3. 3A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers2004 · 108 citations